Serum biomarkers, both biochemical and endocrine, including lipids (LDL, HDL, cholesterol), T2DM markers (free insulin, fasting glucose, HOMA-IR), and hormones (LH, FSH, testosterone, and progesterone), showed altered states in PCOS patients. The gene discussed is BRD2; the disease is polycystic ovary syndrome.